Potential benefits of lipophilic statins appeared to be dose- and duration-dependent, with the greatest reduction in hepatocellular carcinoma risk seen with use of a moderate-dose statin for about two ... Lipophilic statins were associated with
Approved use of the drug has been expanded to include treatment of patients with hepatocellular carcinoma who have been treated with sorafenib. ... The FDA has approved the first treatment for hepatocellular carcinoma in nearly a decade, the agency
Patients with hepatocellular carcinoma (HCC) who take statins after diagnosis may have a lower risk for death, a recent study found.
Liver transplantation is the only curative therapy for hepatocellular carcinoma and for end-stage liver disease. ... washout meets radiologic criteria for hepatocellular carcinoma and, therefore, does not require a lesion biopsy.
Overall, 2,140 (95.2%) patients achieved a sustained virologic response, and 78 (3.5%) patients developed hepatocellular carcinoma during a mean follow-up of 14 months. ... cholangiocarcinoma and hepatocellular carcinoma, and one (1%) developed both
19 Annals of Internal Medicine. Decompensation is complications of advanced cirrhosis that affect morbidity and mortality (e.g., variceal hemorrhage, ascites, hepatic encephalopathy, hepatorenal syndrome, and hepatocellular carcinoma).
Patients with cirrhosis were the focus of several recent studies, which reviewed the evidence behind nutritional assessment, calculated the cost-effectiveness of hepatocellular carcinoma screening, and estimated the prevalence of nonalcoholic
A Taiwanese nationwide cohort study of more than 10,000 patients with chronic hepatitis B showed a statistically significant 29% risk reduction for hepatocellular carcinoma in patients who received daily aspirin ... Daily aspirin may be associated with a
hepatocellular carcinoma increased by 2.1% per year (95% CI, 1.9% to 2.3%; P<0.001) during the study period. ... For hepatocellular carcinoma, women experienced a consistent increase in related mortality while death rates among men slowed after 2011.
Direct-acting antivirals (DAAs) for hepatitis C virus (HCV) infection are associated with higher survival rates after liver transplantation and lower all-cause mortality and hepatocellular carcinoma (HCC) incidence, but not ... damage and